Robert J. Lewandowski, MD, FSIR

Y-90 Segmentectomy and Lobectomy: My Top 5 Technical Pearls

Robert J. Lewandowski , MD, FSIR;

02/07/2022

Evolution of Dosimetry Using Y-90 Glass Microspheres

12/07/2020

Riad Salem , MD, MBA;

Robert J. Lewandowski , MD, FSIR;

Shamar Young , MD;

Juan Gimenez , MD;

12/07/2020

IO Learning

Evolution of Dosimetry Using Y-90 Glass Microspheres

Evolution of Dosimetry Using Y-90 Glass Microspheres presentation at CIO October 2020.

Shamar Young , MD;

Juan Gimenez , MD;

Riad Salem , MD, MBA;

Robert J. Lewandowski , MD, FSIR;

07/29/2021

Clinical Insights

Current Status of Interventional Oncology for Breast Cancer Liver Metastases: Articles From the Official Show Daily for Synergy 2015

03/08/2016

Riad Salem , MD, MBA;

Robert J. Lewandowski , MD, FSIR;

Andrew C. Gordon , BA;

Breast cancer is the most common cancer in women and the second most frequent cause of cancer deaths in women after lung cancer in developed nations.1 Half of patients with metastatic breast cancer (MBC) will be diagnosed with liver...

Breast cancer is the most common...

03/08/2016

IO Learning

My Approach to a Patient With Cholangiocarcinoma

Robert Lewandowski, MD, FSIR, Director of Interventional Oncology, Northwestern University Feinberg School of Medicine, Northwestern University, discusses treatment options for patients w...

Robert J. Lewandowski , MD, FSIR;

07/28/2021

Y-90 Radioembolization: Evolving Concepts

Robert J. Lewandowski , MD, FSIR;

11/14/2019